The higher incidence of coronary artery disease in men is often attributed to androgens. Arterial compliance or 'stiffness' is increasingly regarded as a modifiable risk factor for cardiovascular disease. We wanted to look at the effects of complete androgen withdrawal, on arterial compliance in men. We performed arterial compliance studies on 12 men with complete androgen deprivation as treatment for prostate cancer, and on 12 agematched healthy controls. Central pulse wave velocities were significantly higher in the androgen-deprived men (14.2 ؎ 2.7 vs 11.8 ؎ 1.6 m/sec, P ‫؍‬ 0.02). The cases
Introduction
Raised androgen levels in women are associated with hyperinsulinaemia and an atherogenic lipid profile. 1, 2 It has been suggested that androgens in men might contribute to their higher incidence of cardiovascular disease but evidence conflicts. Herman et al 3 demonstrated that men with complete androgen suppression showed improved endothelial function compared to controls, however hypotestosteronaemia has been linked to myocardial infarction and coronary artery disease in men. 4 Arterial compliance or 'elasticity' is increasingly regarded as a surrogate marker for cardiovascular disease. Decreased central arterial compliance decreases coronary artery perfusion and increases cardiac work-load. 5 Arterial compliance declines with age, hypertension and diabetes, and is improved by antihypertensive drugs and hormone replacement therapy in females. 5, 6 Pulse wave velocity is a validated, inverse measure of arterial compliance, and can be measured non-invasively. 7 The effect of testosterone withdrawal on arterial compliance is not known.
To look at the effect on arterial compliance of withdrawal of testosterone, we studied 12 men with prostate cancer who had been deprived of androgens as treatment for the cancer using LHRH analogues. The effect of this therapy is to cause a 90% fall in testosterone levels and a 50% fall in oestradiol levels. They were compared with 12 age-matched healthy controls. These are preliminary results of a larger cross-sectional study ongoing in our department.
Subjects and methods

Subjects
Twenty-four males were studied. Exclusion criteria were any regular vasoactive medication, any history of cardiovascular disease, diabetes or hyperlipidaemia. The 12 cases with prostate cancer were all in remission as defined by a prostate-specific antigen (PSA) value of Ͻ4 ng/ml. The mean duration of androgen deprivation therapy was 35 months (range 3-120 months). The 12 controls were healthy volunteers who had responded to advertisement locally, or men with benign prostatic hypertrophy who were identified from hospital records.
Study design
The average of three brachial blood pressure readings was taken using an automated cuff (OMRON), the first after 15 min of lying supine, and at 15-min intervals thereafter. The right arm was used for all readings. Peripheral arterial compliance was measured by carotid-radial (C-R) pulse wave velocity using the 'COMPLIOR' system, which calculates the delay between two pulse waves recorded simultaneously. A second measurement of peripheral arterial compliance was recorded using the ECGfinapres method on a Maclab system. Three-lead ECG recording was used with simultaneous pulse pressure recording from the finapres, which was fitted on the middle phalynx of the third finger of the left hand. Central arterial compliance was recorded by measuring the aorto-femoral (A-F) pulse wave velocity. Blood was taken for chemical profile and PSA. Statistical analysis was performed using SPSS version 9 for Windows. The two groups were compared using unpaired Student's t-test. Multivariate analysis was undertaken to correct for blood pressure and smoking history. All data were reported as mean ± s.d.
Results
Baseline characteristics are shown in Table 1 . The cases tended to have a higher brachial systolic blood pressure reading though this difference was not significant (Table 2) . Central pulse wave velocities (A-F) were significantly higher in the androgen- SBP, systolic blood pressure; PWV, pulse wave velocity; A-F, aorto-femoral; A-R, aorto-radial. deprived men (14.2 ± 2.7 vs 11.8 ± 1.6 m/sec, P = 0.02). The mean peripheral pulse wave velocities (A-R) for each group showed no significant difference, by either the COMPLIOR or the ECG-finapres methods.
Discussion
We found that androgen deprivation therapy in men, has an adverse effect on central arterial compliance, however the cases did tend to have a higher (though not significantly) brachial systolic pressure than the controls. Results remained significant after adjustment for brachial blood pressure and smoking history.
It is not known exactly how androgens interact with the cardiovascular system. The difference in brachial systolic pressures could reflect increased peripheral stiffness in the androgen-deprived group. However we did not find a difference in peripheral arterial compliance between cases and controls. Testosterone may mediate the progression of atherosclerotic plaques indirectly (though serum lipid values were similar in both groups in our study), as animal studies suggest. 8 There may be a direct effect on the vessel wall where steroid receptors are known to exist, 9 and testosterone infused into coronary arteries in men with coronary artery disease causes vasodilatation. 10 Infusion of oestradiol does not seem to cause relaxation of male coronary arteries, 11 so fall in oestradiol levels is unlikely to be responsible for the effects on arterial compliance we observed. There may be interaction through insulin pathways as testosterone replacement in middleaged obese men improves insulin sensitivity. 2 Whatever the precise mechanism, testosterone withdrawal is associated with a reduction in central arterial compliance. This was a cross-sectional study only however, so we can only associate these findings. Longitudinal studies are necessary for further confirmation and results of a larger cross-sectional study, which is still ongoing in our department.
Conclusion
Androgen withdrawal in men is associated with an adverse effect on central arterial compliance. The increased risk of cardiovascular disease seen in men cannot be explained by the presence of normal concentrations of androgens. Conversely, androgens have no effect on peripheral arterial compliance. Longitudinal studies are necessary for further confirmation.
